Brown Advisory Inc Iovance Biotherapeutics, Inc. Transaction History

Brown Advisory Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$16.33 - $33.07 $12.4 Million - $25.1 Million	-757,621 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$28.67 - $52.59 $601,811 - $1.1 Million	20,991 Added 2.85%	757,621 $24 Million
Q4 2020 Feb 12, 2021	BUY	$28.04 - $50.26 $420,543 - $753,799	14,998 Added 2.08%	736,630 $34.2 Million
Q3 2020 Nov 16, 2020	BUY	$27.75 - $36.3 $559,301 - $731,626	20,155 Added 2.87%	721,632 $23.8 Million
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $913,684 - $1.38 Million	33,579 Added 5.03%	701,477 $19.3 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $59,518 - $118,337	3,046 Added 0.46%	667,898 $20 Million
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $590,213 - $967,030	32,881 Added 5.2%	664,852 $18.4 Million
Q3 2019 Nov 14, 2019	BUY	$17.99 - $26.0 $11.4 Million - $16.4 Million	631,971 New	631,971 $11.5 Million

319

243M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $923M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.